Parallax Health Sciences Inc (PRLX) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1327 OCEAN AVENUE, SUITE M SANTA MONICA, CA 90401 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 80 - Health Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 0 | 3 | 63 | 912 | 1 | 1 | |||
| Cash and cash equivalent | 0 | 3 | 63 | 912 | 1 | 1 | |||
| Receivables | 44 | 838 | 1,874 | ||||||
| Inventory, net of allowances, customer advances and progress billings | 410 | 831 | ✕ | ||||||
| Inventory | 410 | 831 | |||||||
| Other undisclosed current assets | 9 | 104 | 132 | ||||||
| Total current assets: | 0 | 55 | 1,415 | 3,749 | 1 | 1 | |||
| Noncurrent Assets | |||||||||
| Nontrade receivables | 177 | ✕ | |||||||
| Property, plant and equipment | 10 | 39 | 117 | 10 | 16 | ||||
| Long-term investments and receivables | 170 | 170 | |||||||
| Accounts and financing receivable, after allowance for credit loss | 170 | 170 | |||||||
| Intangible assets, net (including goodwill) | 1,364 | 3,083 | 977 | 4,092 | 18 | 20 | |||
| Goodwill | 785 | 785 | 785 | 3,888 | |||||
| Intangible assets, net (excluding goodwill) | 579 | 2,298 | 192 | 204 | 18 | 20 | |||
| Deposits noncurrent assets | 23 | 23 | |||||||
| Other undisclosed noncurrent assets | 22 | ||||||||
| Total noncurrent assets: | 1,364 | 3,285 | 1,209 | 4,408 | 27 | 35 | |||
| TOTAL ASSETS: | 1,364 | 3,340 | 2,624 | 8,157 | 28 | 36 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 2,655 | 6,027 | 3,974 | 2,788 | 303 | 174 | |||
| Interest and dividends payable | 450 | 1,724 | 804 | ||||||
| Taxes payable | 38 | 35 | |||||||
| Employee-related liabilities | 402 | 368 | 45 | ||||||
| Accounts payable | 831 | 2,021 | 1,458 | ||||||
| Accrued liabilities | 250 | 1,000 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 722 | 876 | 1,632 | 2,788 | 303 | 174 | |||
| Debt | 1,317 | 741 | 96 | ||||||
| Derivative instruments and hedges, liabilities | 24 | ||||||||
| Due to related parties | 1,005 | 1,284 | 425 | 134 | 104 | 922 | |||
| Other undisclosed current liabilities | 115 | 13 | 11 | 999 | 84 | ||||
| Total current liabilities: | 5,116 | 8,065 | 4,410 | 2,922 | 1,501 | 1,180 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 934 | 18,464 | 13,690 | 10,237 | |||||
| Long-term debt, excluding current maturities | 934 | 18,464 | 13,690 | 10,237 | |||||
| Liabilities, other than long-term debt | 525 | 1,167 | 1,357 | ||||||
| Due to related parties | 491 | 1,167 | 1,357 | ||||||
| Derivative instruments and hedges, liabilities | 34 | ||||||||
| Other undisclosed noncurrent liabilities | 740 | 3,034 | 740 | 96 | 190 | ||||
| Total noncurrent liabilities: | 2,199 | 22,665 | 15,788 | 10,333 | 190 | ||||
| Total liabilities: | 7,315 | 30,730 | 20,198 | 13,254 | 1,501 | 1,370 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (5,950) | 6,546 | 17,684 | 17,607 | 14,871 | 15,141 | |||
| Preferred stock | 1 | 1 | 1 | 1 | 1 | ||||
| Common stock | 158 | 137 | 107 | 121 | 163 | ||||
| Common stock, share subscribed but unissued, subscriptions receivable | (0) | (1) | |||||||
| Common stock, value, subscriptions | (2) | ✕ | |||||||
| Additional paid in capital | 13,081 | 6,246 | 2,216 | 1,496 | 1,394 | 397 | |||
| Deferred compensation equity | (1,149) | (1,810) | |||||||
| Accumulated deficit | (19,191) | (2,995) | (1,894) | ||||||
| Warrants and rights outstanding | 1,972 | 15,362 | 15,989 | 16,473 | 16,473 | ||||
| Stockholders' equity note, subscriptions receivable | (1) | (2) | ✕ | ✕ | ✕ | ||||
| Other undisclosed equity, attributable to parent | 1,149 | ||||||||
| Other undisclosed equity | (33,935) | (35,258) | (22,704) | (16,344) | (16,475) | ||||
| Total equity: | (5,950) | (27,390) | (17,574) | (5,097) | (1,473) | (1,334) | |||
| TOTAL LIABILITIES AND EQUITY: | 1,364 | 3,340 | 2,624 | 8,157 | 28 | 36 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 12 | 3,195 | 22,749 | 11,580 | ||||
| Revenue, net | ✕ | ✕ | 3,195 | 22,749 | 11,580 | |||
| Cost of revenue (Cost of Product and Service Sold) | (20) | (3,226) | (19,188) | (9,874) | ||||
| Gross profit: | (9) | (31) | 3,561 | 1,705 | ||||
| Operating expenses | (6,626) | (7,087) | (6,708) | (2,968) | (851) | (486) | ||
| Other undisclosed operating income (loss) | (8) | 12 | ||||||
| Operating loss: | (6,635) | (7,118) | (3,147) | (1,262) | (859) | (473) | ||
| Nonoperating income (expense) | 22,243 | (6,758) | (10,035) | (2,458) | (255) | 31 | ||
| Debt instrument, convertible, beneficial conversion feature | (28) | 473 | ||||||
| Interest and debt expense | 22,858 | 918 | 214 | 247 | (21) | |||
| Income (loss) from continuing operations before income taxes: | 38,466 | (13,877) | (12,264) | (3,506) | (867) | (463) | ||
| Income tax expense | (3) | (21) | ||||||
| Other undisclosed income (loss) from continuing operations | (22,858) | |||||||
| Income (loss) from continuing operations: | 15,608 | (13,879) | (12,285) | (3,506) | (867) | (463) | ||
| Income (loss) before gain (loss) on sale of properties: | 14,784 | (12,925) | (12,285) | (3,506) | (867) | (463) | ||
| Income (loss) from discontinued operations | (824) | 954 | ||||||
| Other undisclosed net income (loss) | 824 | (951) | (897) | (214) | (247) | (42) | ||
| Net income (loss): | 15,608 | (13,877) | (13,182) | (3,720) | (1,113) | (504) | ||
| Other undisclosed net loss attributable to parent | (824) | |||||||
| Net income (loss) attributable to parent: | 14,784 | (13,877) | (13,182) | (3,720) | (1,113) | (504) | ||
| Preferred stock dividends and other adjustments | (33) | |||||||
| Other undisclosed net income available to common stockholders, basic | 33 | |||||||
| Net income (loss) available to common stockholders, diluted: | 14,784 | (13,877) | (13,182) | (3,720) | (1,113) | (504) | ||
Comprehensive Income ($ in thousands)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 15,608 | (13,877) | (13,182) | (3,720) | (1,113) | (504) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 15,608 | (13,877) | (13,182) | (3,720) | (1,113) | (504) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.